MGN1601 / Mologen - LARVOL DELTA

A Review of Clinical Trials of Cancer and Its Treatment as a Vaccine. (PubMed, Rev Recent Clin Trials) - "This brief discussion of vaccines and their varieties with examples also discusses vaccine clinical trials in relation to cancer diseases in this DNA and RNA-based cancer vaccine that has had successful clinical trials like the cervical cancer drug VGX-3100, the kidney cancer drug Pembrolizumab, MGN-1601, the prostate cancer drug pTVG-HP with rhGM-CSF, the melanoma cancer drug proteasome siRNA, and the lung cancer drug FRAME-001."

Journal • Review • Bladder Cancer • Cervical Cancer • Genito-urinary Cancer • Infectious Disease • Kidney Cancer • Lung Cancer • Melanoma • Oncology • Prostate Cancer • Renal Cell Carcinoma • Solid Tumor